Dermatol. praxi. 2019;13(2):76-79 | DOI: 10.36290/der.2019.012

Current trends in the treatment of skin allergies

MUDr. Gabriela Janoušková, MUDr. Alena Machovcová, MBA
Dermatovenerologické oddělení FN v Motole, Praha

Allergic disease have got a long history. They can manifest themselves in various organs, usch as skin, gastrointestinal and respiratory
tract, and comprise disease as allergic rhinitis, conjuctivitis, bronchial asthma, oral allergy syndrome, food allergy, urticaria,
atopic eczema and contact dermatitis.The actual treatment options for urticaria and atopic dermatitis are discussed in this article.

Keywords: allergy, urticaria, atopic dermatitis, treatment

Published: June 10, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janoušková G, Machovcová A. Current trends in the treatment of skin allergies. Dermatol. praxi. 2019;13(2):76-79. doi: 10.36290/der.2019.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lachapelle JM, Maibach HI. Patch Testing and Prick Testing. A Practical Guide. 2nd ed. Berlin: Springer-Verlag; 2009: 195.
    2. Gilles S, Akdis C, Lauener R, et al. The role of environmental factors in allergy: A critical reappraisal. Exp Dermatol. 2018; 27(11): 1193-1200. Go to original source... Go to PubMed...
    3. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA?LEN/EDF/WAO Guideline for definiton, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014; 69: 868-887. Go to original source... Go to PubMed...
    4. Ferrer M, Sastre J, Jáuregui I, et al. Effect of antihistamine up-dosing in chronic urticaria. J Investig Allergol Clin Immunol. 2011; 21(3): 34-39.
    5. Dostupné na: http://www.sukl.cz/modules/medication/detail.php?code=0149028&tab=prices.
    6. Brown MM, Chamlin SL, Smidt AC. Quality of life in pediatric dermatology. Dermatol Clin. 2013; 31(2): 211-221. Go to original source... Go to PubMed...
    7. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010; 105(2): 99-106. Go to original source... Go to PubMed...
    8. Nowicki R, Trzeciak M, Wilkowska A, et al. Atopic dermatitis: current treatment guidelines. Statement of the expert of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postepy Dermatol Alergol. 2015; 32(4): 239-249. Go to original source... Go to PubMed...
    9. Schmutt M, Jiang YJ, Elias PM. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res. 2008; 49(3): 499-509. Go to original source... Go to PubMed...
    10. Eberlein B, Eicke C, Reinhardt HW, et al. Adjuvant treatment of atopic eczema: assement of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol. 2008; 22(1): 73-82. Go to original source...
    11. Wollenberg A, Frank R, Kroth J, et al. Proactive therapy of atopic eczema - an evidence - based concept with a behavioral background. J Dtsch Dermatol Ges 2009; 7(2): 117-121. Go to original source... Go to PubMed...
    12. Čapková Š. Možnosti léčby chronické a chronicky recidivující atopické dermatitidy. Farmakoterapie. 2011; 7(Suppl. 2):19-25.
    13. Záhejský J. Zevní dermatologická terapie a kosmetika. 1. Vydání. Praha: Grada Publishing: 2006: 133.
    14. Mrowietz U, Klein CE, Reich K, et al. Cyclosporine therapy in dermatology. J Dtsch Dermatol Ges. 2009;7(5): 474-479. Go to original source... Go to PubMed...
    15. Bußmann C, Novak N. Systemic therapy of atopic dermatitis. Allergol Select.2017;1(1):1-8. Go to original source... Go to PubMed...
    16. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014; 71(2): 327-349. Go to original source... Go to PubMed...
    17. Grundmann-Kollmann M, Podda M, Ochsendorf F et al. Mycophenolate Mofetil Is Effective in the Treatment of Atopic Dermatitis. Arch Dermatol. 2001;137(7): 870-873. Go to PubMed...
    18. Shah N, Alhusayen R, Walsh S, et al. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study.J Cutan Med Surg. 2018; 22(5): 484-487. Go to original source... Go to PubMed...
    19. Deo M, Yung A, Hill S. Methotrexate for treatment of atopic dermatitis in children and adolescents. Int J Dermatol. 2014; 53(8): 1037-1041. Go to original source... Go to PubMed...
    20. Hanifin JM, Schneider LC, Leung DY, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993; 28(2 Pt 1): 189-197. Go to original source... Go to PubMed...
    21. Thibodeaux Q, Smith MP, Ly K, et al. A review of dupilumab in the treatment of atopic diseases. Hum Vaccin Immunother. 2019 Feb 20. doi: 10.1080/21645515.2019.1582403. Go to original source... Go to PubMed...
    22. Silverberg JI, Simpson EL, Ardeleanu M, et al. Dupilumab provides importantn clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from 2 phase III trials. 2019 Feb 21.doi: 10.1111/bjd.17791.
    23. Dostupné na: http://www.sukl.cz/modules/medication/detail.php?code=0222565&tab=texts.
    24. Heil PM, Maurer D, Klein B, et al. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges. 2010; 8(12): 990-998. Go to original source... Go to PubMed...
    25. Hotze M, Baurecht H, Rodríguez E, et al. Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines. Allergy. 2014; 69(1):132-135. Go to original source... Go to PubMed...
    26. Navarini AA, French LE, Hofbauer GF. Interrupting IL-6 receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J Allergy Clin Immunol. 2011; 128(5): 1128-1130. Go to original source... Go to PubMed...
    27. Sediva A, Kayserova J, Vernerova E, et al. Anti-CD20 (rituximab) treatment for atopic eczema. J Allergy Clin Immunol. 2008;121(6):122-128. Go to original source... Go to PubMed...
    28. Fernandez-Anton Martinez MC, Alfageme Roldan F, Ciudad Blanco C, et al. Ustekinumab in the treatment of severe atopic dermatitis: a preliminaryreport of our expirience with 4 patients. Actas Dermosifiliogr. 2014; 105(3): 213-324. Go to original source... Go to PubMed...
    29. Hambly N, Nair P. Monoclonal antibodies for treatment of refractory asthma. Curr Opin Pulm Med. 2014; 20(1): 87-94. Go to original source... Go to PubMed...
    30. Wilson SR, Thé L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neuron to induces itch. Cell. 2013; 155(2): 285-295. Go to original source... Go to PubMed...
    31. Raap U, Wichmann K, Gehring M, et al. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol. 2012; 23(3): 285-288. Go to original source... Go to PubMed...
    32. Ständer S, Siepmann D, Herrgott I, et al. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One. 2010; 4;5(6): e10968. Go to original source... Go to PubMed...
    33. Samrao A, Berry TM, Goreshi R, et al. A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. Arch Dermatol. 2012; 148(8): 890-897. Go to original source... Go to PubMed...
    34. Camargo CA Jr, Ganmaa D, Sidbury R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014; 134(4): 831-835. Go to original source... Go to PubMed...
    35. Hata TR, Audish D, Kotol P, et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014; 28(6): 781-789. Go to original source... Go to PubMed...
    36. Kaffenberger BH, Mathis J, Zirwas MJ. A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis.J Am Acad Dermatol. 2014; 71(3): 480-483. Go to original source... Go to PubMed...
    37. Kim JE, Kim HJ, Lew BL, et al. Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment. Ann Dermatol. 2015; 27(5): 578-592. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.